{"id":4749,"date":"2026-07-23T11:07:03","date_gmt":"2026-07-23T09:07:03","guid":{"rendered":"https:\/\/mumak.me\/?p=4749"},"modified":"2026-07-23T11:45:22","modified_gmt":"2026-07-23T09:45:22","slug":"valuation-analysis-revolution-medicines","status":"publish","type":"post","link":"https:\/\/mumak.me\/en\/research-insights\/valuation-analysis\/valuation-analysis-revolution-medicines\/","title":{"rendered":"Valuation Analysis: Revolution Medicines"},"content":{"rendered":"\t\t
\n\t\t\t\t
\n\t\t\t\t\t
\n\t\t
\n
\n \t\t\t
<\/circle><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/path><\/svg><\/div>\t\t\n<\/div>\n
\n \t\t\t

Revolution Medicines<\/h4>\n\t\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\n\t\t\t\n\t\t\t
\n\t\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t<\/path><\/svg>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t<\/path><\/svg>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t<\/path><\/svg>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t<\/path><\/svg>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t<\/path><\/svg>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t<\/path><\/svg>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t<\/path><\/svg>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t<\/path><\/svg>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t
\n\t\t\t\t
\n\t\t\t\t\t<\/path><\/svg>\t\t\t\t<\/div>\n\t\t\t\t
\n\t\t\t\t\t<\/path><\/svg>\t\t\t\t<\/div>\n\t\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t<\/div>\n\t\t\t\t\t\t<\/div>\n\t\t\t\t\t

Analysis Result: 3 out of 5 MUMAKS<\/h4>\n\t\t\n<\/div>\n\n<\/div>\n\t\t
\n\t\t\t\t\t\t\t\t\t

Rating<\/h2>

This analysis evaluates Revolution Medicines under the UMBRELLA strategy using the MUMAK method. <\/span><\/p>

The valuation is conducted across five decision-making phases: Geopolitics<\/strong>, Industry<\/strong>, Fundamentals<\/strong>, Market Sentiment<\/strong>, and Technical Analysis.<\/strong><\/span><\/p>

The goal is not to predict the future precisely. The goal is orientation. We contextualize facts, demonstrate causal relationships, and structure a comprehensible decision logic. <\/span> <\/span><\/p>

We explain \u2013 you decide.<\/span><\/b> <\/span><\/p>

Revolution Medicines is a clinical-stage oncology company. The company develops targeted therapies for patients with so-called RAS-addicted cancers. <\/span> <\/span><\/p>

The pipeline is based on a proprietary platform for <\/span>RAS(ON) inhibitors<\/span><\/b>. These agents are designed to suppress active, cancer-promoting RAS signaling across various mutations and tumor types.<\/span> <\/span><\/p>

The lead drug candidate <\/span>daraxonrasib<\/span><\/b> is already in the regulatory preparation and review phase following positive Phase 3 results in pretreated metastatic pancreatic cancer.<\/span> <\/span><\/p>

With <\/span>zoldonrasib<\/span><\/b>, which specifically targets the RAS G12D mutation, Revolution Medicines has a second significant development opportunity. Particularly in pancreatic cancer, this agent could offer substantial long-term therapeutic and commercial potential.<\/span> <\/span><\/p>

Geopolitics<\/h3>

Classification <\/strong><\/h4>

Revolution Medicines is a clinical-stage oncology company. The company develops targeted therapies for patients with so-called RAS-addicted cancers. <\/span> <\/span><\/p>

The pipeline is based on a proprietary platform for <\/span>RAS(ON) inhibitors<\/span><\/b>. These agents are designed to suppress active, cancer-promoting RAS signaling across various mutations and tumor types.<\/span> <\/span><\/p>

The lead drug candidate <\/span>daraxonrasib<\/span><\/b> is already in the regulatory preparation and review phase following positive Phase 3 results in pretreated metastatic pancreatic cancer.<\/span> <\/span><\/p>

With <\/span>zoldonrasib<\/span><\/b>, which specifically targets the RAS G12D mutation, Revolution Medicines has a second significant development opportunity. Particularly in pancreatic cancer, this agent could offer substantial long-term therapeutic and commercial potential.<\/span> <\/span><\/p>

<\/p>

Opportunities<\/span> <\/span><\/h5>